Viewing Study NCT05552469

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:02 PM
Ignite Modification Date: 2026-05-18 @ 5:48 PM
Study NCT ID: NCT05552469
Status: RECRUITING
Last Update Posted: 2025-11-20
First Post: 2022-09-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myeloid Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MDS View
None CMML View
None CCUS View
None CHRS View
None NLRP3 View
None Myelodysplastic Syndromes View
None Chronic Myelomonocytic Leukemia View
None inflammasome View
None CYP2C9 View